withanolide/hearing loss

BACKGROUND OF THE DISCLOSURE 1. Field of the Disclosure The present disclosure generally relates to method for treating hearing loss. More specifically, the method includes administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of

BACKGROUND OF THE DISCLOSURE Field of the Disclosure The present disclosure generally relates to method for treating age-related hearing loss (ARHL) including administering a composition to a mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A,

BACKGROUND OF THE DISCLOSURE Field of the Disclosure The present disclosure generally relates to method for treating congenital cytomegalovirus (cCMV) induced hearing loss. More specifically, the method includes administering a composition to the mammal, wherein the composition consists essentially

BACKGROUND OF THE DISCLOSURE Field of the Disclosure The present disclosure generally relates to method for treating noise-induced hearing loss (NIHL) and, more particularly, to a method for treating NIHL from repeated exposure(s) to high noise levels. The method includes administering a composition

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to a composition for treating hearing loss. More specifically, the composition includes components that provide an additive effect that is equal to or greater than the sum of the effects of the individual